Does therapy with spironolactone increase the effect of ACEIs and ARA-II for managing proteinuria and renal failure progression in patients with chronic renal disease?
¿El tratamiento con espironolactona incrementa el efecto de IECAS y ARAII en el control de la proteinuria y la progresión de la insuficiencia renal en pacientes con ERC?
A. Ramos, C. Caramelo
Read
3400
Timeswas read the article
398
Total PDF
3002
Total HTML
Article information
ISSN: 20132514Original language: English
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 7 | 9 | 0 | 9 |
| 2025 6 | 54 | 0 | 54 |
| 2025 5 | 57 | 0 | 57 |
| 2025 4 | 43 | 0 | 43 |
| 2025 3 | 70 | 0 | 70 |
| 2025 2 | 49 | 0 | 49 |
| 2025 1 | 54 | 0 | 54 |
| 2024 12 | 29 | 0 | 29 |
| 2024 11 | 30 | 0 | 30 |
| 2024 10 | 32 | 0 | 32 |
| 2024 9 | 38 | 0 | 38 |
| 2024 8 | 47 | 0 | 47 |
| 2024 7 | 30 | 0 | 30 |
| 2024 6 | 42 | 0 | 42 |
| 2024 5 | 26 | 0 | 26 |
| 2024 4 | 28 | 0 | 28 |
| 2024 3 | 21 | 3 | 24 |
| 2024 2 | 25 | 15 | 40 |
| 2024 1 | 25 | 7 | 32 |
| 2023 12 | 18 | 7 | 25 |
| 2023 11 | 18 | 7 | 25 |
| 2023 10 | 23 | 9 | 32 |
| 2023 9 | 22 | 8 | 30 |
| 2023 8 | 25 | 6 | 31 |
| 2023 7 | 37 | 7 | 44 |
| 2023 6 | 29 | 2 | 31 |
| 2023 5 | 24 | 8 | 32 |
| 2023 4 | 18 | 2 | 20 |
| 2023 3 | 16 | 0 | 16 |
| 2023 2 | 20 | 6 | 26 |
| 2023 1 | 29 | 0 | 29 |
| 2022 12 | 33 | 3 | 36 |
| 2022 11 | 19 | 3 | 22 |
| 2022 10 | 24 | 1 | 25 |
| 2022 9 | 27 | 4 | 31 |
| 2022 8 | 32 | 7 | 39 |
| 2022 7 | 15 | 0 | 15 |
| 2022 6 | 21 | 3 | 24 |
| 2022 5 | 18 | 7 | 25 |
| 2022 4 | 31 | 1 | 32 |
| 2022 3 | 23 | 5 | 28 |
| 2022 2 | 17 | 4 | 21 |
| 2022 1 | 16 | 0 | 16 |
| 2021 12 | 23 | 5 | 28 |
| 2021 11 | 20 | 1 | 21 |
| 2021 10 | 20 | 3 | 23 |
| 2021 9 | 16 | 2 | 18 |
| 2021 8 | 21 | 9 | 30 |
| 2021 7 | 35 | 2 | 37 |
| 2021 6 | 19 | 1 | 20 |
| 2021 5 | 21 | 1 | 22 |
| 2021 4 | 21 | 9 | 30 |
| 2021 3 | 23 | 1 | 24 |
| 2021 2 | 22 | 0 | 22 |
| 2021 1 | 22 | 6 | 28 |
| 2020 12 | 16 | 0 | 16 |
| 2020 11 | 13 | 4 | 17 |
| 2020 10 | 9 | 0 | 9 |
| 2020 9 | 11 | 0 | 11 |
| 2020 8 | 38 | 5 | 43 |
| 2020 7 | 19 | 2 | 21 |
| 2020 6 | 21 | 3 | 24 |
| 2020 5 | 21 | 6 | 27 |
| 2020 4 | 23 | 5 | 28 |
| 2020 3 | 16 | 8 | 24 |
| 2020 2 | 24 | 3 | 27 |
| 2020 1 | 33 | 5 | 38 |
| 2019 12 | 27 | 3 | 30 |
| 2019 11 | 18 | 8 | 26 |
| 2019 10 | 7 | 0 | 7 |
| 2019 9 | 13 | 2 | 15 |
| 2019 8 | 11 | 0 | 11 |
| 2019 7 | 10 | 3 | 13 |
| 2019 6 | 13 | 3 | 16 |
| 2019 5 | 11 | 2 | 13 |
| 2019 4 | 30 | 1 | 31 |
| 2019 3 | 12 | 0 | 12 |
| 2019 2 | 12 | 3 | 15 |
| 2019 1 | 7 | 0 | 7 |
| 2018 12 | 25 | 12 | 37 |
| 2018 11 | 16 | 4 | 20 |
| 2018 10 | 20 | 13 | 33 |
| 2018 9 | 22 | 4 | 26 |
| 2018 8 | 11 | 8 | 19 |
| 2018 7 | 16 | 8 | 24 |
| 2018 6 | 10 | 9 | 19 |
| 2018 5 | 14 | 8 | 22 |
| 2018 4 | 11 | 8 | 19 |
| 2018 3 | 11 | 9 | 20 |
| 2018 2 | 13 | 4 | 17 |
| 2018 1 | 12 | 7 | 19 |
| 2017 12 | 11 | 11 | 22 |
| 2017 11 | 10 | 6 | 16 |
| 2017 10 | 8 | 12 | 20 |
| 2017 9 | 11 | 5 | 16 |
| 2017 8 | 13 | 6 | 19 |
| 2017 7 | 7 | 4 | 11 |
| 2017 6 | 13 | 4 | 17 |
| 2017 5 | 10 | 2 | 12 |
| 2017 4 | 4 | 1 | 5 |
| 2017 3 | 8 | 1 | 9 |
| 2017 2 | 9 | 4 | 13 |
| 2017 1 | 4 | 0 | 4 |
| 2016 12 | 18 | 4 | 22 |
| 2016 11 | 23 | 3 | 26 |
| 2016 10 | 41 | 4 | 45 |
| 2016 9 | 52 | 6 | 58 |
| 2016 8 | 67 | 0 | 67 |
| 2016 7 | 83 | 0 | 83 |
| 2016 6 | 55 | 0 | 55 |
| 2016 5 | 59 | 0 | 59 |
| 2016 4 | 35 | 0 | 35 |
| 2016 3 | 33 | 0 | 33 |
| 2016 2 | 28 | 0 | 28 |
| 2016 1 | 32 | 0 | 32 |
| 2015 12 | 60 | 0 | 60 |
| 2015 11 | 25 | 0 | 25 |
| 2015 10 | 24 | 0 | 24 |
| 2015 9 | 14 | 0 | 14 |
| 2015 8 | 22 | 0 | 22 |
| 2015 7 | 46 | 0 | 46 |
| 2015 6 | 7 | 0 | 7 |
| 2015 5 | 47 | 0 | 47 |
Show all
